Stifel Nicolaus analyst Mathew Blackman maintained a Hold rating on Endologix Inc (NASDAQ: ELGX) today and set a price target of $5. The company’s shares closed on Friday at $4.96.
Endologix Inc has an analyst consensus of Moderate Buy, with a price target consensus of $5.67.
See today’s analyst top recommended stocks >>
The company has a one-year high of $6.50 and a one-year low of $3.75. Currently, Endologix Inc has an average volume of 510.7K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Endologix, Inc. engages in the research, development, manufacture, and trade of medical devices for the treatment of aortic disorders such as abdominal aortic aneurysms (AAA). Its products include AFX Endovascular AAA System, VELA Proximal Endograft, and Ovation Abdominal Stent Graft System.
